Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Genenta Science
GNTA
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$3.82
0.12
3.24%
Pre-Market: Sep 19, 7:33 PM EDT
15 minutes delayed
Get Report
Comment
Genenta Science (GNTA) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Genenta Science (NASDAQ:GNTA) Stock
Genenta Science Stock (NASDAQ: GNTA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, May 13, 2024
HC Wainwright & Co. Reiterates Buy on Genenta...
Benzinga Newsdesk
Monday, February 12, 2024
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Thursday, February 08, 2024
Genenta Science Has Dosed First Of Three Pati...
Benzinga Newsdesk
Wednesday, November 22, 2023
Why Urban Outfitters Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
Friday, July 28, 2023
Genenta Announces Ongoing Clinical Trial Prog...
Benzinga Newsdesk
Thursday, June 29, 2023
Roth MKM Assumes Genenta Science at Buy, Anno...
Benzinga Newsdesk
Genenta Science Says European Commission Has ...
Benzinga Newsdesk
Wednesday, April 26, 2023
Genenta Reported FY22 Net Loss Of €(8.5)M, Co...
Benzinga Newsdesk
Monday, April 03, 2023
Genenta Announces Extension Of License Agreem...
Benzinga Newsdesk
Thursday, March 02, 2023
FDA Grants Orphan Drug Designation To Genenta...
Benzinga Newsdesk
Tuesday, February 14, 2023
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Wednesday, February 08, 2023
HC Wainwright & Co. Reiterates Buy on Genenta...
Benzinga Newsdesk
Tuesday, February 07, 2023
Genenta Science Enters Development And Manufa...
Benzinga Newsdesk
Thursday, January 05, 2023
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
Benzinga Insights
EF Hutton Initiates Coverage On Genenta Scien...
Benzinga Newsdesk
Friday, September 16, 2022
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Tuesday, September 13, 2022
Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday
Lisa Levin
Monday, September 12, 2022
Why Ventyx Biosciences Is Trading Higher By 70%, Here Are 46 Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Friday, September 09, 2022
Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday
Lisa Levin
Thursday, September 08, 2022
Why Bilibili Is Trading Lower By Over Around 14%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
Monday, July 25, 2022
This Small Cap Cancer Company 'Hijacks Tumors From Within," HC Wainwright Says
Vandana Singh
Benzinga's Top Ratings Upgrades, Downgrades For July 25, 2022
Benzinga Insights
HC Wainwright & Co. Initiates Coverage On Gen...
Benzinga Newsdesk
Wednesday, June 29, 2022
InflaRx Climbs More Than 40%, Here's 58 Biggest Movers From Yesterday
Lisa Levin
Tuesday, June 28, 2022
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Why Is Ceragon Networks Surging By 19%? 41 Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
Thursday, June 23, 2022
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Wednesday, May 04, 2022
Genenta Progresses To Higher Dosing Cohort In...
Benzinga Newsdesk
Monday, May 02, 2022
Genenta ASGCT Clinical Data Highlights Temfer...
Benzinga Newsdesk
Wednesday, April 27, 2022
Genenta Reports Stephen Squinto Steps Down As...
Benzinga Newsdesk
Wednesday, March 30, 2022
53 Biggest Movers From Yesterday
Lisa Levin
Wednesday, March 09, 2022
Genenta Data Presentation At AACR To Describe...
Benzinga Newsdesk
Thursday, March 03, 2022
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Friday, February 25, 2022
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Monday, January 31, 2022
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Thursday, January 13, 2022
Maxim Group Initiates Coverage On Genenta Sci...
Benzinga Newsdesk
Monday, January 10, 2022
The Week Ahead In Biotech (Jan 10-15): JPMorgan Healthcare Conference Front And Center, Preannouncements Keep Coming
Shanthi Rexaline
Sunday, December 19, 2021
The Week Ahead In Biotech (Dec. 19-25): Amgen And Aquestive Regulatory Decisions Key Events Of Holiday-Shortened Week
Shanthi Rexaline
Wednesday, December 15, 2021
Genenta Science Shares Open For Trade At $10....
Benzinga Newsdesk
IPOs For Wednesday, Dec. 15, 2021: Pearl Hold...
Benzinga Newsdesk
Genenta Science S.p.A. Shares Will Open For Q...
Benzinga Newsdesk
The Daily Biotech Pulse: Lilly Raises Guidance, Medtronic Gets FDA Warning Letter, Decision Day For Calliditas, Genenta IPO
Shanthi Rexaline
Friday, December 16, 2011
Genta Reports the Number of Outstanding Share...
Benzinga
Tuesday, September 06, 2011
Genta Completes Financing of up to $12.7M
Benzinga
Monday, August 15, 2011
Friday's OTC Percentage Gainers
Benzinga
Friday, June 03, 2011
Genta Presents Updated Results of Phase 2 Trial of Tesetaxel in Patients With Advanced Gastric Cancer
Benzinga
Monday, May 23, 2011
Phase 3 Trial of Genasense in Advanced Melanoma Does Not Show Significant Increase in Overall Survival
Benzinga
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
